Insider filing · ABT
Daniel Gesua Sive Salvadori
EXECUTIVE VICE PRESIDENT
profile →
Abbott Laboratories
ABT · Healthcare · 65 filings in 24 months
ticker →
Daniel Gesua Sive Salvadori sold $3.1M of Abbott Laboratories (ABT)
Executed Jan 30 2025, disclosed Jan 31 2025, 1 day later.
Value, as filed
$3.1M
23,771 sh × $128.50
Executed
Jan 30 2025
the trade date, as filed
Disclosed
Jan 31 2025
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
DSDaniel Gesua Sive Salvadori (EXECUTIVE VICE PRESIDENT) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Abbott Laboratories (ABT). The largest single filing was $102K of ABT (885 sh × $115.58, as filed), executed Mar 2.
The name
ABTHealthcare · Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Daniel Gesua Sive Salvadori in ABT
ABTSALE
Abbott Laboratories
$102K885 sh × $115.58
Exec Mar 2
Filed Mar 3 · 5:30 PM ET